XML 69 R94.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidating Financial Statements of Guarantors of the Notes (Details 4) (USD $)
In Thousands, unless otherwise specified
1 Months Ended 3 Months Ended 12 Months Ended 12 Months Ended
Mar. 31, 2011
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2011
Dec. 31, 2010
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2010
Predecessor
Sep. 30, 2012
Parent Company
Sep. 30, 2011
Parent Company
Sep. 30, 2009
Parent Company
Sep. 30, 2010
Parent Company
Predecessor
Sep. 30, 2012
Guarantor Subsidiaries
Sep. 30, 2011
Guarantor Subsidiaries
Sep. 30, 2010
Guarantor Subsidiaries
Predecessor
Sep. 30, 2012
Non-Guarantor Subsidiaries
Sep. 30, 2011
Non-Guarantor Subsidiaries
Sep. 30, 2010
Non-Guarantor Subsidiaries
Predecessor
Sep. 30, 2012
Eliminations
Sep. 30, 2011
Eliminations
Sep. 30, 2010
Eliminations
Predecessor
Cash flows from operating activities:                                                  
Income from continuing operations                   $ 146,471 $ 29,919 $ 213,670 $ 146,471 $ 29,919   $ 213,670 $ 199,395 $ 168,576 $ 245,601 $ 91,164 $ 58,478 $ 63,288 $ (290,559) $ (227,054) $ (308,889)
Adjustments to reconcile net income to net cash and cash equivalents provided by operating activities:                                                  
Equity in earnings of subsidiaries                         (290,559) (227,054)   (308,889)             290,559 227,054 308,889
Impairments and disposals of assets, net                   764 2,104 10,417         266 1,555 10,033 498 549 384      
Loss from discontinued operations   9,029 13,925 768 (674) 1,950 668 1,590 (1,428) 23,048 2,780 1,352               23,048 2,780 1,352      
Depreciation of property, plant and equipment                   58,311 55,589 47,505 5,275 4,840   4,909 37,603 36,211 30,548 15,433 14,538 12,048      
Amortization of intangible assets                   43,960 44,086 15,841         40,680 40,405 14,324 3,280 3,681 1,517      
Foreign currency translation loss/(gain)                   (289) 64 1,042 (12) (331)   1,234       (277) 395 (192)      
Stock-based compensation                   2,680 1,788 23,109 2,482 1,506   21,865 72 179 617 126 103 627      
Amortization of financing fees                   14,411 15,076 1,412 14,411 15,076   1,412                  
Write-off of financing fees 20,824                 9,289 20,824   9,289 20,824                      
Allowance for doubtful accounts                   297 5,468 1,256         297 5,468 1,256            
Amortization of incremental inventory fair value                 122,104   122,104             83,952     38,152        
Inventory reserves                   (2,652) 22,364 934         (2,652) 22,364 934            
Deferred income taxes                   (17,057) (30,934) (13,000)         (23,852) (30,934) (17,751) 6,795   4,751      
Excess income tax benefit from exercise of stock options                       (6,646)       (6,646)                  
Changes in operating assets and liabilities, net of acquisitions:                                                  
Accounts receivable                   (22,380) (9,692) 22,988         (18,843) (10,132) 21,759 (3,537) 440 1,229      
Inventories                   (44,790) (38,934) (18,373)         (28,139) (10,887) (5,106) (16,651) (28,047) (13,267)      
Other assets                   (2,147) 8,943 (3,755)         2,066 4,303 2,890 (4,213) 4,640 (6,645)      
Accounts payable                   16,097 28,101 17,150         14,220 25,261 (4,959) 1,877 2,840 22,109      
Accrued expenses and other liabilities                   5,491 3,082 52,108         (14,924) (14,936) 39,131 20,415 18,018 12,977      
Intercompany accounts                         279,288 321,271   353,896 (153,706) (297,364) (317,852) (125,582) (23,907) (36,044)      
Cash provided by operating activities of continuing operations                   231,504 282,732 367,010 166,645 166,051   281,451 52,483 24,021 21,425 12,376 92,660 64,134      
Cash provided by operating activities of discontinued operations                   2,546 1,905 4,742               2,546 1,905 4,742      
Net cash provided by operating activities                   234,050 284,637 371,752 166,645 166,051   281,451 52,483 24,021 21,425 14,922 94,565 68,876      
Cash flows from investing activities:                                                  
Purchase of property, plant and equipment                   (86,314) (43,999) (69,454) (20,287) (1,652)   (1,829) (41,182) (17,443) (21,279) (24,845) (24,904) (46,346)      
Net proceeds from sale of discontinued operations                   515     515                        
Proceeds from sale of investments                       2,000       2,000                  
Cash paid for acquisitions                     (3,987,809) (14,200)   (3,983,806)       (3,196)     (807) (14,200)      
Cash used in investing activities of continuing operations                   (85,799) (4,031,808) (81,654)   (3,985,458)   171   (20,639) (21,279)   (25,711) (60,546)      
Cash used in investing activities of discontinued operations                     (235) (449)                 (235) (449)      
Net cash used in investing activities                   (85,799) (4,032,043) (82,103) (19,772) (3,985,458)   171 (41,182) (20,639) (21,279) (24,845) (25,946) (60,995)      
Cash flows from financing activities:                                                  
Principal payments under long-term debt agreements and capital leases                   (229,375) (13,554) (56,410) (224,325) (13,125)   (56,264)   (429) (146) (5,050)          
Termination of interest rate swaps                       (5,813)       (5,813)                  
Payments of financing fees                     (138,227) (1,524)   (138,227)   (1,524)                  
Excess income tax benefit from exercise of stock options                       6,646       6,646                  
Proceeds from borrowings                     2,400,000     2,400,000                      
Capital contribution                   15 1,550,400     1,550,400                      
Proceeds from stock options exercised                       10,621 15     10,621                  
Cash (used in) provided by financing activities of continuing operations                   (229,360) 3,798,619 (46,480)   3,799,048   (46,334)   (429) (146)            
Cash used in financing activities of discontinued operations                     (381) (747)                 (381) (747)      
Net cash (used in) provided by financing activities                   (229,360) 3,798,238 (47,227) (224,310) 3,799,048   (46,334)   (429) (146) (5,050) (381) (747)      
Effect of exchange rate changes on cash and cash equivalents                   1,839 (2,909) (1,940)           335   1,839 (3,244) (1,940)      
Net (decrease) increase in cash and cash equivalents                   (79,270) 47,923 240,482 (77,437) (20,359)   235,288 11,301 3,288   (13,134) 64,994 5,194      
Change in cash for discontinued operations   1,071       3,734       1,071 3,734 2,350               1,071 3,734 2,350      
Cash and cash equivalents at beginning of year         393,335       341,678 393,335 341,678 98,846 261,098 281,457 46,169 46,169 3,288     128,949 60,221 52,677      
Cash and cash equivalents at end of year   $ 315,136       $ 393,335       $ 315,136 $ 393,335 $ 341,678 $ 183,661 $ 261,098 $ 46,169 $ 281,457 $ 14,589 $ 3,288   $ 116,886 $ 128,949 $ 60,221